State Street Corporation 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 07:27 am Sale |
2024-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
STATE STREET CORP STT |
8,328,817 5.200% |
-1,591,048 (-16.04%) |
Filing |
| 2024-10-16 10:04 am Sale |
2024-09-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
STATE STREET CORP STT |
9,919,865 6.200% |
-1,612,223 (-13.98%) |
Filing |
| 2024-01-25 09:21 am Purchase |
2023-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
STATE STREET CORP STT |
11,532,088 7.390% |
352,510 (+3.15%) |
Filing |
| 2023-02-02 12:34 pm Purchase |
2022-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
STATE STREET CORP STT |
11,179,578 7.290% |
11,179,578 (New Position) |
Filing |